IRB System Revisions Discussed At June 11 House Hearing
This article was originally published in The Gray Sheet
Executive Summary
Institutional review boards should not have to duplicate functions performed by industry or government, such as reviewing adverse event reports, the Health Industry Manufacturers Assocation says in written testimony submitted to the House Government Reform/Human Resources Subcommittee at a June 11 hearing on IRBs.